↓ Skip to main content

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

twitter
13 tweeters

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Published in
Journal for Immunotherapy of Cancer, October 2018
DOI 10.1186/s40425-018-0421-z
Pubmed ID
Authors

Bin Zhao, Hong Zhao, Jiaxin Zhao

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 17%
Researcher 7 15%
Student > Postgraduate 7 15%
Student > Bachelor 4 9%
Other 4 9%
Other 9 19%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 22 47%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Immunology and Microbiology 2 4%
Nursing and Health Professions 1 2%
Other 4 9%
Unknown 13 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2018.
All research outputs
#2,858,010
of 17,882,239 outputs
Outputs from Journal for Immunotherapy of Cancer
#516
of 1,828 outputs
Outputs of similar age
#62,770
of 285,252 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 2 outputs
Altmetric has tracked 17,882,239 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,828 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,252 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.